Roche makes changes in its corporate executive committee
pharmafile | December 15, 2011 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing | Roche
Roche has made two new appointments in its corporate executive committee.
Sophie Kornowski-Bonnet, currently general manager of Roche in France, has been appointed head of Roche partnering.
Dan Zabrowski will become a member of the diagnostics leadership team and report to Daniel Day, chief operating officer of Roche diagnostics.
Kornowski-Bonnet will assume her new role on 1 February 2012, and will also join Roche’s enlarged corporate executive committee, reporting to Severin Schwan, chief executive of the Roche group.
She will relocate to group’s headquarters in Basel, Switzerland and will succeed Dan Zabrowski, who will take over the position as head of Roche applied science in the diagnostics division, located in Penzberg, Germany, as of 1 February.
Kornowski-Bonnet was born in Paris, earned a doctorate in pharmacy from the University Paris V in 1986 and an MBA in marketing and finance from the University of Chicago in 1989.
Before joining Roche in 2007 she assumed various management roles in other international pharma companies.
Zabrowski, who is an American citizen, earned a PhD in organic chemistry at the University of Indiana in 1987.
In 1993 he joined Syntex, which was acquired by Roche in 1994. During his career at Syntex and Roche, he has held a number of management positions in pharma development.
Related Content

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

Roche candidate shows early promise for treating haemophilia A
Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

Roche advances treatment for Parkinson’s disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, …






